c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells

Blood
Jay L HessRobert K Slany

Abstract

Abdominal-type HoxA genes in combination with Meis1 are well-documented on-cogenes in various leukemias but it is unclear how they exert their transforming function. Here we used a system of conditional transformation by an inducible mixed lineage leukemia-eleven-nineteen leukemia (MLL-ENL) oncoprotein to overexpress Hoxa9 and Meis1 in primary hematopoietic cells. Arrays identified c-Myb and a c-Myb target (Gstm1) among the genes with the strongest response to Hoxa9/Meis1. c-Myb overexpression was verified by Northern blot and quantitative reverse transcription-polymerase chain reaction (RT-PCR). Also MLL-ENL activated c-Myb through up-regulation of Hoxa9 and Meis1. Consequently, short-term suppression of c-Myb by small inhibitory RNA (siRNA) efficiently inhibited transformation by MLL-ENL but did not impair transformation by transcription factor E2A-hepatic leukemia factor (E2A-HLF). The anti c-Myb siRNA effect was abrogated by coexpression of a c-Myb derivative with a mutated siRNA target site. The introduction of a dominant-negative c-Myb mutant had a similar but weaker effect on MLL-ENL-mediated transformation. Hematopoietic precursors from mice homozygous for a hypo-morphic c-Myb allele were more severely affected and coul...Continue Reading

References

Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·G SauvageauR K Humphries
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·P S KnoepflerM P Kamps
Mar 19, 1999·Molecular and Cellular Biology·W F ShenC Largman
Apr 28, 1999·Advances in Cancer Research·B Ganter, J S Lipsick
Jun 23, 1999·Oncogene·K Weston
Sep 21, 2000·Leukemia Research·O AfonjaK Takeshita
Dec 13, 2000·Molecular and Cellular Biology·U ThorsteinsdottirG Sauvageau
Nov 1, 2001·Proceedings of the National Academy of Sciences of the United States of America·K R CalvoM P Kamps
Dec 4, 2001·Nature Genetics·Scott A ArmstrongStanley J Korsmeyer
May 16, 2003·Molecular and Cellular Biology·Jon Mar BjörnssonStefan Karlsson
Jun 12, 2003·Genes, Chromosomes & Cancer·Alexander KohlmannTorsten Haferlach
Jul 26, 2003·Cancer Letters·Dirk GeertsRogier Versteeg
Nov 8, 2003·Blood·Sheri Tinnell DorsamH Jeffrey Lawrence
Jan 1, 2004·Molecular and Cellular Biology·Bernd B ZeisigRobert K Slany
May 4, 2005·Current Opinion in Hematology·Carolina Abramovich, R Keith Humphries
May 28, 2005·Cancer Letters·Dirk GeertsRogier Versteeg
Jun 17, 2005·Annals of the New York Academy of Sciences·Carolina AbramovichR Keith Humphries
Aug 18, 2005·International Journal of Hematology·Takuro Nakamura
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Thomas A MilneJay L Hess

❮ Previous
Next ❯

Citations

Feb 6, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Arndt Borkhardt
May 16, 2008·Molecular Genetics and Genomics : MGG·Lior Cohen, Adi Salzberg
Jan 29, 2008·International Journal of Hematology·Yali Dou, Jay L Hess
May 11, 2010·International Journal of Hematology·Tim C P Somervaille, Michael L Cleary
Jan 5, 2013·International Journal of Hematology·Ly P VuStephen D Nimer
Aug 10, 2012·Leukemia·D R Pattabiraman, T J Gonda
Jan 24, 2013·Leukemia·G VolpeS Dumon
Jun 25, 2008·Nature Reviews. Cancer·Robert G Ramsay, Thomas J Gonda
Oct 16, 2007·Oncogene·B Argiropoulos, R K Humphries
Jun 24, 2010·Current Opinion in Hematology·James D PhelanH Leighton Grimes
Mar 23, 2006·The American Journal of Chinese Medicine·Den-En ShiehChun-Ching Lin
Jan 23, 2010·The Journal of Clinical Investigation·Shenghao JinAlan M Gewirtz
Jul 9, 2009·Blood·Maike SchwiegerCarol Stocking
Apr 7, 2009·Blood·Shane R HormanH Leighton Grimes
Sep 20, 2012·Blood·Constanze BreitingerRobert K Slany
Apr 30, 2013·PloS One·Ayten KandilciGerard C Grosveld
Jun 19, 2009·Haematologica·Robert K Slany
Dec 18, 2013·The Journal of Clinical Investigation·Chinavenmeni S VeluH Leighton Grimes
Oct 27, 2009·Future Oncology·Christian Bach, Robert K Slany
Nov 21, 2013·Nucleic Acids Research·Jitendra K ThakurGitanjali Yadav
Jul 9, 2014·Proceedings of the National Academy of Sciences of the United States of America·Sean M LawCharles L Brooks
Feb 25, 2014·International Journal of Hematologic Oncology·Andrew G Muntean
Feb 19, 2008·Current Problems in Pediatric and Adolescent Health Care·Patrick A Zweidler-McKay, Joanne M Hilden
Apr 1, 2008·Experimental Hematology·Bob ArgiropoulosR Keith Humphries

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.